(Q39556660)

13 September 2017

title

Prostaglandin synthetase inhibitors in the treatment of primary dysmenorrhea. Outcome trials reviewed (English)

1 reference

13 September 2017

1 reference

P R Owen

1

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 January 1984

1 reference

American Journal of Obstetrics and Gynecology

13 September 2017

published in

1 reference

13 September 2017

volume

148

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

96-103

1 reference

Alleged Psychogenic Disorders in Women — A Possible Manifestation of Sexual Prejudice

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

Prostaglandins in reproductive physiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

Trial of prostaglandin-synthetase inhibitors in primary dysmenorrhoea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

Flufenamic acid in treatment of primary spasmodic dysmenorrhoea. A double-blind crossover study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

Mefenamic Acid in Dysmenorrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

Treatment of Primary Dysmenorrhea with Mefenamic Acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

The objective evaluation of dysmenorrhea therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

Prostaglandins in primary dysmenorrhea. Comparison of prophylactic and nonprophylactic treatment with ibuprofen and use of oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

Analgesic efficacy of ibuprofen for treatment of primary dysmenorrhea.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

The effect of ibuprofen on the intrauterine pressure and menstrual pain of dysmenorrheic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

Effect of ibuprofen on menstrual blood prostaglandin levels in dysmenorrheic women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

Indomethacin in the treatment of primary dysmenorrhoea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

The relief of primary dysmenorrhea by ketoprofen and indomethacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

Primary Dysmenorrhea Treated with Indomethacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

Prostaglandins, indomethacin and dysmenorrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

Treatment of Primary Dysmenorrhea with Prostaglandin Synthetase Inhibitors—a Promising Therapeutic Alternative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

Comparison between fluproquazone and indomethacin in treatment of primary dysmenorrhoea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

The effect of naproxen-sodium on the intrauterine pressure and menstrual pain of dysmenorrheic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

Naproxen in dysmenorrhoea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

The effect of naproxen-sodium on the prostaglandin concentrations of the menstrual blood and uterine “jet-washings” in dysmenorrehic women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

Treating dysmenorrhea with anti-inflammatory agents: a double-blind trial with naproxen sodium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

Naproxen suppositories in primary dysmenorrhoea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

Anaprox in dysmenorrhea: Reduction of pain and intrauterine pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

New concepts in dysmenorrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

7 January 2021

Side-Effects of Prostaglandin Synthetase Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

7 January 2021

Prostaglandin Synthetase Inhibitors and Dysmenorrhea: A Survey and Personal Clinical Experience

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

7 January 2021

Ibuprofen therapy for primary dysmenorrhea in a university student health service

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

7 January 2021

Suppression of Menstrual Prostaglandins and Relief of Dysmenorrhea with Ibuprofen

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

7 January 2021

Naproxen and Indomethacin in the Treatment of Primary Dysmenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

7 January 2021

Clinical Experience of Naproxen in the Treatment of Primary Dysmenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

7 January 2021

Naproxen and Naproxen Sodium in Dysmenorrhea: Development from in vitro Inhibition of Prostaglandin Synthesis to Suppression of Uterine Contractions in Women and Demonstration of Clinical Efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2884%2980039-3

7 January 2021

10.1016/S0002-9378(84)80039-3

Identifiers

DOI

1 reference

13 September 2017

1 reference